MediPharm Labs Corp. (OTCMKTS:MEDIF – Get Free Report) saw a large decrease in short interest in August. As of August 31st, there was short interest totaling 997 shares, a decrease of 94.3% from the August 15th total of 17,636 shares. Based on an average daily volume of 108,289 shares, the short-interest ratio is currently 0.0 days.
MediPharm Labs Price Performance
Shares of MediPharm Labs stock traded up $0.00 during mid-day trading on Friday, hitting $0.06. 44,896 shares of the stock were exchanged, compared to its average volume of 78,146. MediPharm Labs has a twelve month low of $0.04 and a twelve month high of $0.08. The company has a 50-day simple moving average of $0.05 and a 200 day simple moving average of $0.05.
About MediPharm Labs
MediPharm Labs Corporation is a Canada-based company focused on the extraction, formulation and manufacturing of pharmaceutical-grade cannabis products. Through proprietary processes and a GMP-compliant facility in Mississauga, Ontario, the company produces high-purity distillates, isolates and advanced formulations tailored to both medical and adult-use markets.
The company’s core offerings include THC and CBD distillates, crystalline isolates, softgel capsules, oral thin films and sterile injectable products.
Featured Stories
- Five stocks we like better than MediPharm Labs
- Rocket Lab Tackles a Supply Chain Bottleneck as the Stock Hunts for a Bottom. Time to Buy?
- Optical Cable Corporation Is Starting to Get the Market’s Attention
- Oil Above $100 Is Creating a New Opportunity Beyond the Major Producers
- Is Nike’s Index Demotion a Warning or a Buying Opportunity?
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
